Androgen and estrogen (alpha) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat.
The periaqueductal gray (PAG) is involved in many gonadal steroid-sensitive behaviors, including responsiveness to pain. The PAG projects to the rostral ventromedial medulla (RVM), comprising the primary circuit driving pain inhibition. Morphine administered systemically or directly into the PAG produces greater analgesia in male compared to female rats, while manipulation of gonadal hormones alters morphine potency in both sexes. It is unknown if these alterations are due to steroidal actions on PAG neurons projecting to the RVM. The expression of androgen (AR) and estrogen (ERalpha) receptors in the PAG of female rats and within this descending inhibitory pathway in both sexes is unknown. The present study used immunohistochemical techniques (1) to map the distribution of AR and ERalpha across the rostrocaudal axis of the PAG; and (2) to determine whether AR and/or ERalpha were colocalized on PAG neurons projecting to the RVM in male and female rats. AR and ERalpha immunoreactive neurons (AR-IR, ERalpha-IR) were densely distributed within the caudal PAG of male rats, with the majority localized in the lateral/ventrolateral PAG. Females had significantly fewer AR-IR neurons, while the quantity of ERalpha was comparable between the sexes. In both sexes, approximately 25-50% of AR-IR neurons and 20-50% of ERalpha-IR neurons were retrogradely labeled. This study provides direct evidence of the expression of steroid receptors in the PAG and the descending pathway driving pain inhibition in both male and female rats and may provide a mechanism whereby gonadal steroids modulate pain and morphine potency.
Loyd
Dayna R
DR
Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 4010, Atlanta, GA 30302-4010, United States.
Murphy
Anne Z
AZ
D000818:Animals; D003627:Data Interpretation, Statistical; D047628:Estrogen Receptor alpha / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism* / Q000648:ultrastructure; D009474:Neurons / Q000378:metabolism* / Q000648:ultrastructure; D010477:Perfusion; D010487:Periaqueductal Gray / Q000378:metabolism* / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D011944:Receptors, Androgen / Q000378:metabolism* / Q000648:ultrastructure; D012727:Sex Characteristics; D016707:Tissue Fixation; D014621:Vagina / Q000166:cytology / Q000648:ultrastructure
D047628:Estrogen Receptor alpha; D011944:Receptors, Androgen
Psychopharmacology (Berl). 2002 Sep;163(2):183-93
12202965
J Neurosci. 1998 May 15;18(10):3967-76
9570823
Pain. 2005 Mar;114(1-2):71-80
15733633
Horm Behav. 1991 Jun;25(2):217-28
2066081
Neuroscience. 2004;125(1):243-53
15051163
Brain Res. 1999 Mar 6;821(1):224-30
10064807
Neuroendocrinology. 1995 Nov;62(5):487-97
8559280
Exp Brain Res. 1991;86(1):108-16
1661679
Science. 1969 Apr 25;164(3878):444-5
4887743
J Comp Neurol. 1993 Feb 1;328(1):76-87
8429127
J Pain. 2005 Jun;6(6):372-83
15943959
Pharmacol Biochem Behav. 2000 Oct;67(2):271-9
11124391
Pharmacol Biochem Behav. 1992 Jan;41(1):153-8
1539065
Horm Behav. 1999 Oct;36(2):98-108
10506534
Brain Res. 1988 Jan 26;439(1-2):95-106
3359200
Percept Mot Skills. 2003 Feb;96(1):201-11
12705527
Prog Neurobiol. 1995 Aug;46(6):575-605
8545545
Eur J Neurosci. 2008 Mar;27(6):1517-24
18364026
Neurosci Biobehav Rev. 2000 May;24(3):375-89
10781697
Am J Physiol. 1979 Nov;237(5):R278-84
495775
Pharmacol Biochem Behav. 1989 Sep;34(1):119-27
2626443
Neurosci Lett. 1998 Jan 2;240(1):13-6
9488163
Brain Res. 2002 Mar 1;929(1):1-9
11852025
J Comp Neurol. 2001 Sep 17;438(2):191-212
11536188
J Comp Neurol. 2002 Jan 28;443(1):27-42
11793345
Neuroscience. 2002;109(3):619-34
11823071
Exp Physiol. 2002 Mar;87(2):275-9
11856974
Behav Neurosci. 1993 Dec;107(6):1093-8
8136063
Genes Brain Behav. 2004 Feb;3(1):20-6
14960012
Neurosci Biobehav Rev. 2001 Dec;25(7-8):669-78
11801292
J Neurophysiol. 1998 Nov;80(5):2244-54
9819240
Trends Neurosci. 1994 Sep;17(9):379-89
7817403
Neuroendocrinology. 1998 Jan;67(1):18-28
9485165
Pain. 1986 Oct;27(1):63-68
3785964
Brain Res. 1993 Apr 2;607(1-2):61-80
8481812
Neurosci Lett. 1999 May 21;267(1):17-20
10400238
Brain Res. 1996 Apr 15;716(1-2):224-8
8738244
J Comp Neurol. 2006 Jun 10;496(5):723-38
16615128
Am J Physiol. 1979 Nov;237(5):R285-90
495776
J Comp Neurol. 2007 Jul 1;503(1):198-208
17480015
J Comp Neurol. 2000 Apr 17;419(4):532-42
10742719
J Neurophysiol. 1994 Sep;72(3):1337-56
7807216
Neuroscience. 2007 Jun 29;147(2):456-68
17540508
Neuroendocrinology. 1996 Jan;63(1):53-60
8839355
Eur J Pharmacol. 2000 Mar 31;392(3):157-61
10762669
J Neurosci. 1999 Apr 1;19(7):2823-33
10087093
Brain Res. 1998 Aug 31;804(1):21-35
9729249
Science. 1980 Oct 10;210(4466):193-5
7414330
J Neurosci. 1987 Jan;7(1):271-8
3806198
Physiol Behav. 1991 Apr;49(4):673-7
1881968
Brain Res. 2005 Oct 12;1059(1):13-9
16153618
Brain Res. 1999 Aug 14;838(1-2):151-7
10446327
J Comp Neurol. 2004 Aug 30;476(4):348-62
15282710
Brain Res. 2002 Dec 20;958(1):139-45
12468038
Physiol Behav. 1990 Sep;48(3):409-16
2267250
Peptides. 1986 Jan-Feb;7(1):155-9
3520509
Exp Brain Res. 1992;90(2):307-18
1397145
J Pain. 2005 Apr;6(4):261-74
15820914
Pain. 2003 Jun;103(3):285-302
12791435
J Neurosci Res. 2003 Mar 15;71(6):802-10
12605406
Physiol Behav. 1993 Jul;54(1):45-53
8392209
J Pain. 2007 Jun;8(6):494-502
17383238
Horm Behav. 2001 Dec;40(4):472-82
11716576
Neurosci Lett. 2004 May 6;361(1-3):262-4
15135943
Brain Res. 1979 Jul 6;170(1):85-93
223721
J Pharmacol Exp Ther. 2002 Feb;300(2):695-701
11805235
Behav Brain Res. 1985 Apr;15(2):107-19
2859869